ZEROID

ZEROID is a South Korean dermocosmetic skincare brand launched by Neopharm in 2002 [1]. It grew out of hospital and clinic use before expanding to the general consumer market, and it specialises in products for chronic skin conditions such as dryness, atopic dermatitis and acne. The name is a contraction of "Zero" and "Steroid," signalling the brand's central promise: results for irritated and compromised skin without the steroids commonly used in such treatments [2].

The brand remains active. Its parent, Neopharm Co., Ltd., is publicly listed on the KOSDAQ exchange (ticker 092730), and ZEROID was named No.1 Professional/Clinical Brand of 2024, with continued distribution across Korean, European and US retail channels [3][4].

ZEROID was created by Neopharm, a Korean skin-science company founded in 2000 and headquartered in Daejeon [5]. From the outset the line was positioned as medical or professional-use skincare, developed for clinical and dermatological settings rather than as a conventional cosmetic range. According to Korean review platform Hwahae, the brand "expanded from hospital and clinic expertise to the general consumer market" [1].

The steroid-free concept is the brand's founding idea. Steroid creams are effective for many chronic skin conditions but can carry long-term side effects and withdrawal symptoms, and ZEROID was built around delivering comparable soothing results without them.

ZEROID's formulations are built on Neopharm's proprietary MLE technology, short for Multi-Lamellar Emulsion. The company describes MLE as a system that recreates a three-dimensional structure similar to that of the human skin barrier, using a combination of Ceramide-9S, cholesterol or phytosterol, and stearic acid to reinforce the skin's own barrier function [6]. Ceramide-9S is described by the brand as one of its patented components, working as an alternative to the natural ceramide found in human skin lipids.

A second signature ingredient is Defensamide. According to Neopharm, Defensamide stimulates the skin's production of antimicrobial peptides and helps restrain the growth of Staphylococcus aureus, a bacterium associated with atopic dermatitis. The company frames both technologies as barrier-repair science rather than symptom suppression.

The range is organised around skin concerns, from mild care for sensitive and dry skin to intensive care for severely dry or disordered skin, and formulations aimed at oily and combination skin. Its most-reviewed products on Hwahae include the Intensive Cream and Soothing Cream, alongside Soothing and Intensive lotions and the Pimprove line for acne-prone skin. The brand's formulas are positioned as hypoallergenic and fragrance-free [2].

ZEROID is one of several brands owned by Neopharm Co., Ltd. Its sister brands include ATOPALM, a non-steroid line for sensitive and baby skin; Real Barrier, an adult dermo-cosmetic range; and Derma-B, focused on body moisturisers. Within this portfolio, ZEROID occupies the professional and clinical position, described by Neopharm's chief executive as the group's professional-use line for clinical and dermatological settings [7].

ZEROID positions itself as a dermatologist-guided, clinical brand rather than a lifestyle skincare label. Its stated approach is to pursue safe, effective care for chronic skin conditions without relying on steroids, focusing instead on restoring the skin's natural barrier. The brand markets itself under the line "Providing a professional solution for healthy skin," and reports being trusted by over 4,000 hospitals and clinics in Korea [8]. According to the brand, its products are suitable for all age groups and are recommended in particular for infants and people with atopic dermatitis [1].

ZEROID was awarded the No.1 Professional/Clinical Brand of 2024 [3]. It has drawn editorial attention from K-beauty publications and retailers; DrFive has described it as "Korea's Number One Dermocosmetic Brand," and UK retailer Skin Cupid has covered it as a clinic-level range available without a prescription [4][2]. On Hwahae, the brand carries roughly 17,000 user reviews across more than 50 products, with the Intensive Cream among its highest-rated items.

ZEROID is active. It is backed by its publicly listed parent Neopharm, holds a recent 2024 industry award, and is distributed across Korea as well as European and US K-beauty retail channels [3]. One point of ambiguity concerns its web presence: the brand's own site at zeroid.com is retained as the official address, but it could not be reached programmatically during research, so the brand's copy here is drawn from Neopharm's official parent-company page and corroborating editorial and retail sources [5].